Outset Medical (OM) has made a splashing public debut, as a combination of hyper growth and medical technology is very hot at this moment. There is a great deal to like about the company, including an inherent strong and interesting product. Moreover, appeal comes from the hyper growth and the fact that recent FDA action essentially quadrupled the addressable market, thereby creating tons of potential to create lasting (spectacular) revenue growth.
The Business
Outset is a medtech company which aims to reduce the cost and complexity of dialysis through its Tablo Hemodialysis System